Skip to main
IMVT
IMVT logo

Immunovant Inc (IMVT) Earnings Dates & Reports

Immunovant Inc (IMVT) Most Recent Earnings

Report Date
Period EndingQ2 2026
Est. EPS-$0.72
Actual EPS-$0.73
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Immunovant Inc (IMVT) Earnings per Share (EPS) History

Signup for full access
Browse free

Immunovant Inc (IMVT) Latest Earnings

The value each IMVT share was expected to gain vs. the value each share gained.

Immunovant Inc (IMVT) reported its most recent earnings on for Q2 2026, posting earnings per share (EPS) of -$0.73. This exceeded analysts' expectations of -$0.72 by 1.39%, marking a Miss.

For comparison, Immunovant Inc reported EPS of -$0.74 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.71.

Immunovant Inc (IMVT) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2026
-$0.71
Q2 2026
-$0.72-$0.73+1.39%
DeckReportListen
Q1 2026
-$0.68-$0.71+4.41%
DeckReportListen
Q4 2025
-$0.72-$0.64-11.11%
DeckReportListen
Q3 2025
-$0.76-$0.760.00%
DeckReportListen
View all

Immunovant Inc (IMVT) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Immunovant Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Immunovant Inc (IMVT) Earnings FAQs

Immunovant Inc (IMVT) last reported earnings on Nov 10, 2025 for Q2 2026, posting an EPS of -$0.73, which Miss the estimate of -$0.72 by 1.39%.

For Q2 2026, Immunovant Inc (IMVT) reported an EPS of -$0.73, missing analysts' estimate of -$0.72 by 1.39%.

For Q2 2026, Immunovant Inc (IMVT) Miss expectations with an actual EPS of -$0.73 vs. an estimated EPS of -$0.72.

Following the last earnings report on Nov 10, 2025, Immunovant Inc (IMVT)'s stock price moved — from — to —.

The next Immunovant Inc (IMVT) earnings call is scheduled for Feb. 5, 2026, where executives will discuss financial results and outlook.

Immunovant Inc (IMVT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.